000			01523 a2200385 4500
005			20250515165139.0
264		0	_c20090915
008			200909s 0 0 eng d
022			_a1879-0852
024	7		_a10.1016/j.ejca.2009.03.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchmidt, Marjanka K
245	0	0	_aRegulatory aspects of genetic research with residual human tissue: effective and efficient data coding. _h[electronic resource]
260			_bEuropean journal of cancer (Oxford, England : 1990) _cSep 2009
300			_a2376-82 p. _bdigital
500			_aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aBRCA1 Protein _xgenetics
650	0	4	_aBRCA2 Protein _xgenetics
650	0	4	_aBreast Neoplasms _xgenetics
650	0	4	_aConfidentiality _xlegislation & jurisprudence
650	0	4	_aDNA Mutational Analysis
650	0	4	_aFemale
650	0	4	_aForms and Records Control
650	0	4	_aGerm-Line Mutation _xgenetics
650	0	4	_aHumans
650	0	4	_aInformed Consent _xlegislation & jurisprudence
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aTissue Banks _xlegislation & jurisprudence
700	1		_aVermeulen, Eric
700	1		_aTollenaar, Rob A E M
700	1		_aVan't Veer, Laura J
700	1		_avan Leeuwen, Flora E
773	0		_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 45 _gno. 13 _gp. 2376-82
856	4	0	_uhttps://doi.org/10.1016/j.ejca.2009.03.008 _zAvailable from publisher's website
999			_c18795263 _d18795263